Głuszczyk, Agnieszka, et al. “Challenges and Risks of Using GLP-1 Antagonists in Treating Type 2 Diabetes and Obesity”. Quality in Sport, vol. 17, Aug. 2024, p. 53683, doi:10.12775/QS.2024.17.53683.